跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
EPTIFIBATIDE INJECTION
Authorized
STANDARD
EPTIFIBATIDE INJECTION
Juno Pharmaceuticals Corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
61a02c2a06622d7e
Company
Juno Pharmaceuticals Corp.
Type
Standard
Approval Details
Approval Id
61a02c2a06622d7e
Drug Approval Canada Name
EPTIFIBATIDE INJECTION
Product Name
EPTIFIBATIDE INJECTION
Status
Marketed
Status Date
2024-05-16
Original Market Date
2024-05-16
Din
02540819
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
20:12.18
Atc Original
B01AC16 EPTIFIBATIDE
Atc Name
b 01 ac 16
Aig Number
0137621001
Company Name
Juno Pharmaceuticals Corp.
Company Address
402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7
Active Ingredients
EPTIFIBATIDE
0.75 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
61a02c2a06622d7e
Type
Standard
Back to Health Canada Approvals
EPTIFIBATIDE INJECTION - Health Canada Drug Approval Details